Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sravathi AI Pancreatic Cancer PROTAC
- Development stage
- Preclinical
- Lead developer
- Sravathi AI Technology
- Modality
- PROTACs (E3 ligase recruitment) → Targeted Protein Degraders (TPDs) → Small Molecules, Bivalent/Multivalent Binders → Multivalent & Scaffold-Based Small Molecules → Small Molecules
01
Overview
Sravathi AI Technology is developing a proteolysis-targeting chimera (PROTAC) for the treatment of pancreatic cancer. This therapeutic candidate is designed to utilize the cell's natural protein degradation machinery by recruiting an E3 ubiquitin ligase to a specific, though currently undisclosed, target protein. By facilitating the ubiquitination and subsequent proteasomal degradation of the target, the drug aims to inhibit oncogenic signaling pathways relevant to pancreatic cancer progression. As of early 2024, the program is in the Lead Identification (Lead ID) stage of preclinical discovery.
- Other names
- Protac
Beyond the preview
Go deeper on Sravathi AI Pancreatic Cancer PROTAC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sravathi AI Pancreatic Cancer PROTAC.